BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 35619946)

  • 21. Emerging roles for extracellular vesicles in tissue engineering and regenerative medicine.
    Lamichhane TN; Sokic S; Schardt JS; Raiker RS; Lin JW; Jay SM
    Tissue Eng Part B Rev; 2015 Feb; 21(1):45-54. PubMed ID: 24957510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular Vesicles: A Brief Overview and Its Role in Precision Medicine.
    Shang M; Ji JS; Song C; Gao BJ; Jin JG; Kuo WP; Kang H
    Methods Mol Biol; 2017; 1660():1-14. PubMed ID: 28828643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine.
    Ilahibaks NF; Lei Z; Mol EA; Deshantri AK; Jiang L; Schiffelers RM; Vader P; Sluijter JPG
    Cells; 2019 Nov; 8(12):. PubMed ID: 31775322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Update on Regulation of Regenerative Medicine in Taiwan.
    Chao WY; Chang YT; Tsai YT; Huang MC; Lin YC; Wu MM; Chi JF; Lin CL; Cheng HF; Wu SM
    Adv Exp Med Biol; 2023; 1430():211-219. PubMed ID: 37526850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Governmental Regulatory System for Stem Cell-Based Therapies in Japan.
    Hara A; Sato D; Sahara Y
    Ther Innov Regul Sci; 2014 Nov; 48(6):681-688. PubMed ID: 30227468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet-rich plasma-derived extracellular vesicles: A superior alternative in regenerative medicine?
    Wu J; Piao Y; Liu Q; Yang X
    Cell Prolif; 2021 Dec; 54(12):e13123. PubMed ID: 34609779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering pro-angiogenic biomaterials via chemoselective extracellular vesicle immobilization.
    Xing Y; Yerneni SS; Wang W; Taylor RE; Campbell PG; Ren X
    Biomaterials; 2022 Feb; 281():121357. PubMed ID: 34999538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Long Journey of Extracellular Vesicles towards Global Scientific Acclamation.
    Pirisinu M
    Adv Pharm Bull; 2023 Jul; 13(3):489-501. PubMed ID: 37646064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Development of Extracellular Vesicle-Integrated Biomaterials for Bone Regeneration.
    Zhou Y; Xiao Y
    Adv Exp Med Biol; 2020; 1250():97-108. PubMed ID: 32601940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulatory science research to facilitate the development of cell/tissue-processed products].
    Sato Y; Tsutsumi H; Sawada R; Suzuki T; Yasuda S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2013; (131):16-9. PubMed ID: 24340665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelial Progenitor Cell-Derived Extracellular Vesicles: A Novel Candidate for Regenerative Medicine and Disease Treatment.
    Xing Z; Zhao C; Liu H; Fan Y
    Adv Healthc Mater; 2020 Jun; 9(12):e2000255. PubMed ID: 32378361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterisation of Extracellular Vesicles from Equine Mesenchymal Stem Cells.
    Soukup R; Gerner I; Gültekin S; Baik H; Oesterreicher J; Grillari J; Jenner F
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular vesicles as therapeutic tools in cardiovascular diseases.
    Fleury A; Martinez MC; Le Lay S
    Front Immunol; 2014; 5():370. PubMed ID: 25136343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of extracellular vesicles isolated from human mesenchymal stem cells by different isolation methods and visualisation of their uptake.
    Zhao AG; Shah K; Cromer B; Sumer H
    Exp Cell Res; 2022 May; 414(2):113097. PubMed ID: 35276207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stem cell-derived extracellular vesicles: role in oncogenic processes, bioengineering potential, and technical challenges.
    Ullah M; Qiao Y; Concepcion W; Thakor AS
    Stem Cell Res Ther; 2019 Nov; 10(1):347. PubMed ID: 31771657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive Quality Control of the Regenerative Therapy Using Platelet Concentrates: The Current Situation and Prospects in Japan.
    Kawase T; Okuda K
    Biomed Res Int; 2018; 2018():6389157. PubMed ID: 29951539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flood Control: How Milk-Derived Extracellular Vesicles Can Help to Improve the Intestinal Barrier Function and Break the Gut-Joint Axis in Rheumatoid Arthritis.
    Aarts J; Boleij A; Pieters BCH; Feitsma AL; van Neerven RJJ; Ten Klooster JP; M'Rabet L; Arntz OJ; Koenders MI; van de Loo FAJ
    Front Immunol; 2021; 12():703277. PubMed ID: 34394100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manufacturing Exosomes: A Promising Therapeutic Platform.
    Colao IL; Corteling R; Bracewell D; Wall I
    Trends Mol Med; 2018 Mar; 24(3):242-256. PubMed ID: 29449149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.
    Rani S; Ryan AE; Griffin MD; Ritter T
    Mol Ther; 2015 May; 23(5):812-823. PubMed ID: 25868399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.